Volumetric 3D printing is an exciting technology that could lead to extremely rapid production of 3D printed parts by curing every particle of the object at once. Now, researchers from Utrecht University are applying the process to bioprinting and have 3D printed functioning liver units at centimeter scale in less than 20 seconds. The results were published in Advanced Materials.
To accomplish this feat, the team relied on volumetric bioprinting (VBP) with a Tomolite system from Readily3D, a spin-out of Switzerland’s Ecole polytechnique fédérale de Lausanne. The system casts UV light from a 405 nm laser beam onto a rotating vat of cell-laden photopolymer, curing the material. Key to the technology was the ability to make cells transparent so that the light could cure the vat without light scattering from the medium.
The process was able to produce centimeter-scale 3D structures in under 20 seconds. While the printing itself took less than a minute, the printed cell-laden structures were cultured in liver differentiation media for 10 days. The cells used were organoids, which are tiny 3D structures able to express important organ-like behavior. However, organoids are difficult to utilize because it can be difficult to structure them without damaging them in the process. Due to the layerless and contactless approach of VBP, the organoids are handled more gently than an extrusion-based technique. In turn, organoid viability, shape, and function is maintained post-printing.
The bioprinted organoids were able to demonstrate key liver functions that included the production of albumin, which prevents fluid from leaking out of blood vessels and into tissues, as well as liver-specific enzyme activity, and polarization. This last characteristic is important as it means that the 3D printed structures were capable of “directional transfer and secretion of compounds from and towards the apical or basolateral side of the cell.” Moreover, the research team experimented with different lattice shapes with varying degrees of curving, determining that the detoxification of ammonia could be improved depending on the geometry of the structure.
Study author Riccardo Levato, Associate Professor from Utrecht University, told 3D Printing Media Network (3DMN), “Via bioprinting, we also create different porous structures that can be perfused with nutrients, and “replace” the role of blood vessels,” Levato also told 3dpbm. “These bioprinted liver units of such clinically relevant sizes open new opportunities for regenerative medicine and for developing new patient-specific models to study new drugs against liver diseases.”
This isn’t the first tissue that Readily3D’s printers have been used to make. Previously, the company’s technology was utilized to 3D print pancreases (seen above). The company is still in its nascent stages, but bioprinting as a whole is taking off. Because bioprinted organs for transplant will likely take some time, the more timely question here might not be when will Readily3D’s technology is used to make complete organs, but when will the firm get acquired by BICO or 3D Systems.
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and recieve information and offers from thrid party vendors.
You May Also Like
3D Printing News Briefs, May 18, 2022: Xerox, Full-Color Materials, & More
In 3D Printing News Briefs today, we’re starting off with metal, as RIT and Xerox are partnering to advance metal AM with a new system installation. Moving on, Stratasys has...
3D Printing Webinar and Event Roundup: May 15, 2022
This is a big week in the additive manufacturing industry—RAPID + TCT is here! But that’s not the only event in town; there will also be webinars on topics like...
Stratasys Advances Applications with New Materials, Software, and Composite 3D Printers
In the last two months, Stratasys Ltd. (NASDAQ: SSYS) has qualified its Antero 840CN03 filament for 3D printed aerospace applications, published its first Sustainability Report, announced the latest two members of its...
Buying the Death Star: Ultimaker Merges with MakerBot. Takes Stratasys Investment
When I used to work at Ultimaker, Makerbot was the enemy. They were closed, corporate, didn’t care about customers and didn’t care about values and open hardware. We did everything...